CDKN2A and pachyonychia congenita: Vasen et al. monitored 77 germline CDKN2A mutation carriers with magnetic resonance imaging (MRI) or magnetic resonance cholangiopancreatography (MRCP), and detected 7 (9.1%) resectable PC cases, concluding that further studies are warranted [25].